Interleukin 17A deficiency alleviates neuroinflammation and cognitive impairment in an experimental model of diabetic encephalopathy

Interleukin 17A (IL-17A) was previously shown to be a key pro-inflammatory factor in diabetes mellitus and associated complications. However, the role of IL-17A in diabetic encephalopathy remains poorly understood. In this study, we established a mouse model of diabetic encephalopathy that was defic...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Xiao-Xia, Xu, Fen-Fen, Liu, Zhan, Cao, Bei-Bei, Qiu, Yi-Hua, Peng, Yu-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165367/
https://www.ncbi.nlm.nih.gov/pubmed/35662228
http://dx.doi.org/10.4103/1673-5374.339490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165367/
https://www.ncbi.nlm.nih.gov/pubmed/35662228
http://dx.doi.org/10.4103/1673-5374.339490

Ejemplares similares